Members of the Return of Individual Results MRCT Center Workgroup (2017) and subsequent Taskforce (2021) contributed to concepts and content presented on this website, and participated in its review.

The MRCT Center would like to express thanks to all current and past workgroup/taskforce members for their commitment and contributions towards this work.

This website represents a consensus viewpoint, and does not necessarily represent the point of view of any individual member organization. Further, the individuals served in their individual capacity not as a representative of the affiliated organization or entity.

Taskforce (2021)

Sylvia Baedorf KassisMRCT Center
Barbara E. BiererMRCT Center / Brigham and Women’s Hospital / Harvard Medical
Linda ColemanYale University
Anna Kang LiuGenentech / Roche
David LeventhalPfizer
Nancy Levitan PoorvuPatient Advocate
Megan McBrideJanssen
Lisa MurrayMRCT Center
Sandra PruckaIndiana University
Kate RobinsPatient Advocate
Jessica ScottTakeda
Jamie TyronePatient Advocate
Carol WeilNational Cancer Institute
Sarah WhiteMRCT Center

Many thanks to those who reviewed these updated resources: Jim Armbrust, Paddy Cullinan

Workgroup (2017)

Carmen AldingerMRCT Center
Mary Ellen AllenGenentech / Roche
Mark BarnesMRCT Center/Ropes & Gray/Yale Law School
Karina BienfaitMerck
Barbara BiererMRCT Center / Brigham and Women’s Hospital/ Harvard Medical
Juan CarmonaMRCT Center
Poorvi ChablaniBiogen
Karla ChildersJohnson & Johnson
Cathryn ClaryNovartis
Linda ColemanQuorum Review IRB
Deborah CollyarPatient Advocates In Research (PAIR)
Kelly CoulbourneAstraZeneca
Patrick CullinanTakeda Pharmaceuticals
Roberta DriscollDana-Farber Cancer Institute
Ricardo Eccard da SilvaBrazilian Health Surveillance Agency – Anvisa
Arianna FrancaJohns Hopkins University
Elizabeth FrankDana Farber/Harvard Cancer Center
Zachary HallinanClinical Trials Transformation Initiative
Lea HartyPfizer
Nicole HintonBiogen
Tab (Tabassum) HodaAmgen
Jaime HoudeEMD Serono
Cheryl JerniganSusan G. Komen
Michael JohnsonMRCT Center
Scott KennedyNovartis
Youngshin KimBeijing United Family Hospital and Clinics
Barbara KressMerck
Sarah LarsonBiogen
David LeventhalPfizer
Rebecca LiMRCT Center/ Brigham and Women’s Hospital/ Harvard Medical School
Dylan MarashiMRCT Center Intern
Gloria MasonHarvard Medical School
Debra Mathews (Co-Chair)Johns Hopkins Berman Institute of Bioethics
Megan McBrideJanssen/Johnson & Johnson
Jules MitchelTarget Health Inc.
Thomas MorganNovartis
Dana Leff NiedzielskaAugust Research
P. Pearl O'RourkePartners HealthCare
Jane PerlmutterGemini Group
Usharani PingaliNizam's Institute of Medical Sciences, India
Wasana PrasitsuebsaiGlaxoSmithKline; formerly: HIV-NAT, the Thai Red Cross AIDS Research Centre, Thailand
Sandy Prucka (Co-Chair)Eli Lilly and Company
David Pulford (Co-Chair)GlaxoSmithKline, United Kingdom
Stephen RosenfeldQuorum Review IRB
Jessica ScottGlaxoSmithKline
Jina ShahGenentech / Roche
Lana SkirbollSanofi
Lynn SleeperBoston Children's Hospital/Harvard Medical School
Adrian ThorogoodGlobal Alliance for Genomics and Health
Carol WeilNational Cancer Institute, USA
Crispin WoolstonSanofi
Sheila YoungGlaxoSmithKline